Control of Von Willebrand Factor Multimer Size by Thrombospondin-1
Open Access
- 11 June 2001
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 193 (12) , 1341-1350
- https://doi.org/10.1084/jem.193.12.1341
Abstract
Plasma von Willebrand factor (vWF) is a multimeric protein that mediates adhesion of platelets to sites of vascular injury. Only the very large vWF multimers are effective in promoting platelet adhesion in flowing blood. A protein disulfide bond reductase in plasma reduces the average multimer size of vWF secreted by endothelial cells. This activity has been isolated from human endothelial cell conditioned medium and shown to be the trimeric glycoprotein, thrombospondin-1 (TSP-1). Incubation of purified TSP-1 with vWF resulted in formation of thiol-dependent complexes of TSP-1 and vWF, generation of new thiols in vWF, and reduction in the average multimer size of vWF. The ratio of the concentrations of TSP-1 and vWF in plasma reflected with average multimer size of vWF. The higher the plasma TSP-1/vWF molar ratio, the smaller the average vWF multimer size. In addition, administration of TSP-1 to mice resulted in reduction in the average multimer size of plasma vWF. Interaction of TSP-1 with vWF is mediated by TSP-1 type 1 properdin domains and the vWF A3 domain. These results indicate that TSP-1 regulates the multimeric size and therefore hemostatic activity of vWF.Keywords
This publication has 46 references indexed in Scilit:
- Thrombospondin sequence motif (CSVTCG) is responsible for CD36 bindingPublished by Elsevier ,2004
- Catalysis of Disulfide Isomerization in Thrombospondin 1 by Protein Disulfide IsomeraseBiochemistry, 1996
- Calcium Ion Binding to Thrombospondin 1Journal of Biological Chemistry, 1995
- Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin.The Journal of cell biology, 1992
- Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between Type I and Type II, von Willebrand??s diseaseBlood Coagulation & Fibrinolysis, 1991
- Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complexBiochemistry, 1988
- Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.Journal of Clinical Investigation, 1986
- Factor VIII/von Willebrand Factor has potent lectin activityBiochemical and Biophysical Research Communications, 1984
- Variant von Willebrand's DiseaseJournal of Clinical Investigation, 1980
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970